Capromorelin
897 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
897
Total Reports
174
Deaths Reported
1940.0%
Death Rate
Active Ingredients
Capromorelin
Administration Routes
OralUnknownOtherOphthalmicTopical
Species Affected
Dog 533
Cat 237
Unknown 120
Human 6
Rabbit 1
Most Affected Breeds
Unknown 126
Domestic Shorthair 117
Dog (unknown) 57
Cat (unknown) 45
Retriever - Labrador 40
Crossbred Canine/dog 33
Chihuahua 25
Shih Tzu 25
Shepherd Dog - German 18
Domestic Mediumhair 18
Most Reported Reactions
Vomiting 135
Lethargy (see also Central nervous system depression in 'Neurological') 122
Death by euthanasia 112
Not eating 94
Lack of efficacy - NOS 90
Hypersalivation 83
Lethargy (see also Central nervous system depression in Neurological) 75
Diarrhoea 74
UNPALATABLE 73
Behavioural disorder NOS 60
Death 59
Bradycardia 58
Outcome Breakdown
Recovered/Normal
270 (34.6%)
Outcome Unknown
221 (28.3%)
Ongoing
112 (14.4%)
Euthanized
111 (14.2%)
Died
64 (8.2%)
Recovered with Sequela
2 (0.3%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.